Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Codexis to Participate in Two Virtual Investment Conferences | ||
By: GlobeNewswire - 27 May 2020 | Back to overview list |
|
REDWOOD CITY, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment conferences:
A live webcast and replay of the Jefferies Conference presentation will be available on the Investors section of the company’s website, http://ir.codexis.com/. About Codexis, Inc. Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see www.codexis.com Contact: LHA Investor Relations |
||
|
||
Copyright 2020 GlobeNewswire | Back to overview list |